Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis

Nephrology

Volumn 13, Issue 4, 2008, Pages 278-283

  Fukuoka, Kousuke ^a   Nakao, Kazushi ^a   Morimoto, Hisanori ^a   Nakao, Ai ^a   Takatori, Yuji ^a   Arimoto, Katsuhiko ^a   Taki, Masafumi ^a   Wada, Jun ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Glycated albumin; Glycohemoglobin; Haemodialysis; Survival

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE MARKER; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RELIABILITY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMODIALYSIS UNITS, HOSPITAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 43449133555     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00864.x     Document Type: Article

References (20)

1. The Diabetes Control and Group Trial Research. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1993 329 : 977 86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 53.
3. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 2003 348 : 383 93.
4. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOPNIDDM trial. JAMA 2003 290 : 486 94.
5. Wu MS, Yu CC, Yang CW et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol. Dial. Transplant. 1997 12 : 2105 10.
6. Okada T, Nakao T, Matsumoto H et al. Predialysis factors related to prognosis in type 2 diabetic patients on chronic dialysis in Japan. Nephrology 2002 7 : 250 56.
7. Morioka T, Emoto M, Tabata T et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes. Care. 2001 24 : 909 13.
8. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. Kidney. Int. 2006 70 : 1503 9.
9. Goldstein DE, Little RR, Lorenz RA et al. Tests of glycemia in diabetes. Diabetes. Care. 2004 27 : 1761 73.
10. Little RR, Tennill AL, Rohlfing C et al. Can glycohemoglobin be used to assess glycemic control in patients with chronic renal failure? Clin. Chem. 2002 48 : 784 6.
11. Uehlinger DE, Gotch FA, Sheiner LB. A pharmacodynamic model of erythropoietin therapy for uremic anemia. Clin. Pharmacol. Ther. 1992 51 : 76 89.
12. Inaba M, Okuno S, Kumeda Y et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 2007 18 : 896 903.
13. Shima K, Ito N, Abe F et al. High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia 1988 31 : 627 31.
14. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes. Care. 1995 18 : 440 47.
15. Chujo K, Shima K, Tada H, Oohashi T, Minakuchi J, Kawashima S. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J. Med. Invest. 2006 53 : 223 8.
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes. Care. 1997 20 : 1183 97.
17. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S. An enzymatic method for the measurement of glycated albumin in biological samples. Clin. Chim. Acta. 2002 324 : 61 71.
18. Feldt-Rasmussen B. Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Kidney. Int. 2006 70 : 1392 4.
19. Takahashi S, Uchino H, Shimizu T et al. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: Usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J. 2007 54 : 139 44.
20. Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia 2007 50 : 549 54.